Pharmacovigilance: Antiretroviral drug safety monitoring in BC

Presenter information:

Katherine Lepik BSc(Pharm), MSc
Research Coordinator, BC- CfE Pharmacovigilance Initiative

On completion of this webinar, attendees will be able to:

  • Understand drug safety surveillance methods and terminology
  • Describe antiretroviral drug safety monitoring in BC
  • Know how to report a suspected adverse drug reaction

Cost: Free registration.

Please register for the webinar by clicking the following link:

click here.

This event is accredited by the College of Family Physicians of Canada and the British Columbia Chapter for up to 1 Mainpro+ credit [Mainpro Event ID: 195702-009].

*Please note this webinar will be recorded and a copy made available for viewing on BC-CfE’s Education and Training website at: education.bccfe.ca/webinars

If you have any questions regarding this event, please contact BC-CfE’s Education and Training team at: education@bccfe.ca.

Event Details

Days
Hours
Minutes
Seconds
Start Date
End Date
Event Category
Attendees of the BC-CfE Learning Series will be able to:
  • Summarize and describe epidemiological, behavioural, virological, and other related research relevant to the management of people living with HIV and other syndemic conditions
  • Describe and demonstrate up-to-date information regarding the care of people living with HIV and syndemic conditions (including viral hepatitis and substance use) particularly in regards to primary care, antiretroviral therapy and other treatments, and comorbid conditions
  • Review new and emerging issues in the context of the management of people living with HIV and other syndemic conditions
  • Identify both clinical and community resources to support the care of people living with HIV and syndemic conditions.
Scroll to Top

The British Columbia Centre for Excellence in HIV/AIDS Laboratory has discontinued gp-41 resistance testing as T-20 (enfuvirtide/Fuzeon) is no longer available in Canada as of March 31, 2025